Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • kovaliuk
    Junior Member
    • Jul 2012
    • 6

    #1

    SRA metadata structure

    Hello,

    We know from the SRA article in NAR that the SRA metadata model has 6 objects (http://www.oxfordjournals.org/nar/database/summary/1456)
    i. Study – high level info e.g. goals of the study, literature references – may be linked to BioProject dbase
    ii. Sample – may be linked to BioSample databases
    iii. Experiment – library information; instrument information
    iv. Run – library information; instrument information
    v. Analysis – analysis results e.g. alignments, assemblies
    vi. Submission – groups the other objects
    And that: ‘A Study consists of a series of Experiments with unique Samples. The Experiment in turn, consists of a number of Runs.’
    Our Big Question is:
    What is the object of interest – what do people refer to – is it the experiment? The study? The run? We are interested in this because we are trying to map the data flows and so which object(s) should we be following?

    We are also interested in:
    useful diagrams or descriptions the way that the metadata in the SRA is structured, including the relationships between the metadata objects
    Definitions of what a ‘run’ is.
  • Torst
    Senior Member
    • Apr 2008
    • 275

    #2
    It's good to see I am not the only one who gets confused with the SRA data model :-)

    I tried to think of it as a tree, but it is really a forest/graph. We use the Study accession number in publications, but then we usually only have one Experiment.

    How sure are you of the statement "A Study consists of a series of Experiments with unique Samples. The Experiment in turn, consists of a number of Runs." ?

    I do know that a Run can contain multiple Samples. This occurs when you multiplex samples into a single lane on Illumina for example. The same Sample could also be in multiple Runs, say you sequence it with Illumina and 454. And so on.

    Comment

    • drdoodlebug
      Junior Member
      • May 2012
      • 5

      #3
      The SRA submission portal is driving me over the edge. I have a massively multiplexed 454 16s pyrotag run, do I really have to create a biosample for every one of my 100+ samples??? Another question about naming objects, where does it ever end? I'm trying to put up a single run and I swear I've created a baker's dozen names for each step. There has to be a better system. I'm beginning to understand why I pull up American pubs that have their data deposited with EBI and DDBJ. Grrr!

      Comment

      • Torst
        Senior Member
        • Apr 2008
        • 275

        #4
        Originally posted by drdoodlebug View Post
        The SRA submission portal is driving me over the edge. I have a massively multiplexed 454 16s pyrotag run, do I really have to create a biosample for every one of my 100+ samples???
        Yes you do. But you can do it all quite easily using the "Generic.tsv" tab separated file you can create with a script or with some Excel wizardry. The online portal allows you to download it, or email sra@ncbi and they will send it to you.

        For the SRA metadata, they have a 5 sheet Excel document you can fill out for bulk submissions too. Just email sra@ncbi. They have been very helpful for our bulk (>100 sample) submissions.

        Comment

        • drdoodlebug
          Junior Member
          • May 2012
          • 5

          #5
          Thanks for the help. I'll give it a try.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
            by SEQadmin2



            CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

            Despite this, “CRISPR helped turn genome editing from a specialized technique into
            ...
            07-31-2026, 11:01 AM
          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            07-20-2026, 11:48 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 08-06-2026, 07:41 AM
          0 responses
          23 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 08-03-2026, 10:13 AM
          0 responses
          33 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-31-2026, 02:55 AM
          0 responses
          43 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-24-2026, 12:17 PM
          0 responses
          26 views
          0 reactions
          Last Post SEQadmin2  
          Working...